Longevity & Functional Medicine
Genomic Medicine
Knowing our genome means discovering who we are on a biological level in order to prevent and avoid future illness.
‘Predict in order to prevent’ is the basis of preventative medicine. Our aim is to identify the risk of suffering from certain illnesses to offer guidance and take the necessary measures to prevent them.
It has been shown that early treatment and appropriate lifestyle habits allow prevention guidelines to be established before the onset of symptoms and other unwanted effects.
Diagnostic Tests
SHA VIP Complete
This is the most complete personalized genetic study. It includes the analysis of polymorphisms in 86 genes. It reports risks in different areas of pathology, including weight control/obesity, cardiovascular risk, liver detoxification, osteoporosis, emotional health, risk of periodontitis, and skin quality.
NEUROgenes
This genomic test assesses the risk of the most common neurodegenerative disorders and is used as a basis for preventive measures.
FEMgenes
With this genomic test we can predict the risk of breast cancer and/or thrombosis if hormone therapy is carried out during menopause.
Global PGX Farmagen
This study evaluates polymorphisms in genes involved in the metabolism of most medications. We seek to avoid toxic reactions or therapeutic failures through personalized therapy.
CARDIOgenes
This genomic test is used in the prevention of cardiovascular diseases.
SPORADICgenes
We study polymorphisms in a group of genes that predict the risk of developing non-hereditary breast cancer. In this way we can perform the appropriate preventive measures to avoid it.
OBESgenes
Studies the predisposition to obesity linked to certain genetic polymorphisms.
